The Evolving Landscape in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Best Practice Clinical Applications of Current Evidence and New Guideline Recommendations

Learn how the experts individualize treatments and manage toxicities associated with established and emerging therapies in CLL/SLL in this program centered around a dynamic live symposium at ASCO 2023. Download slides, watch the on-demand webcast, and read an expert-authored commentary summarizing the key learning points from the live symposium, and download NCCN Guidelines for Patients® as a clinical resource for use in your clinic

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC

Supporters

Supported by educational grants from AstraZeneca, BeiGene Ltd, and Lilly. Supported by independent educational grants from Merck & Co., Inc., Rahway, NJ, USA, and Pharmacyclics, an AbbVie Company and Janssen Biotech, Inc.

AstraZeneca

BeiGene, Ltd.

Janssen Biotech, Inc.

Lilly

Merck Sharp & Dohme Corp.

Pharmacyclics LLC, an AbbVie Company

Partners

Clinical Care Options, LLC

ProCE Banner